| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA4041059 | A | Drug level in human blood treated with [3H]-labeled N-(4-Amino-3,4-dioxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide assesseed as cytosolic carbonyl reductase-mediated compound formation | Homo sapiens | 1 | single protein format | Scientific Literature | ||
| 2. | ALA4041060 | A | Drug level in human hepatocytes treated with [3H]-labeled N-(4-Amino-3,4-dioxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide assesseed as cytosolic carbonyl reductase-mediated compound formation | Homo sapiens | 1 | cell-based format | Scientific Literature | ||
| 3. | ALA4041061 | A | Drug level in monkey blood treated with [3H]-labeled N-(4-Amino-3,4-dioxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide assesseed as cytosolic carbonyl reductase-mediated compound formation | Macaca mulatta | 1 | assay format | Scientific Literature | ||
| 4. | ALA4041062 | A | Drug level in monkey hepatocytes treated with [3H]-labeled N-(4-Amino-3,4-dioxo-1-phenylbutan-2-yl)-2-(3-(4-fluorophenyl)-1H-pyrazol-1-yl)nicotinamide assesseed as cytosolic carbonyl reductase-mediated compound formation | Macaca mulatta | 1 | cell-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!